ABcann Global Appoints New Independent Chair
October 17, 2017 07:00 ET
|
ABcann Medicinals
NAPANEE, Ontario, Oct. 17, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) today announces that Ken Clement, founder and Executive Chair, has decided to...
ABcann Global Appoints Barry Fishman as Chief Executive Officer
September 07, 2017 08:00 ET
|
ABcann Medicinals
NAPANEE, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce the appointment of Barry Fishman as Chief Executive...
ABcann Global files Q2 2017 Financial Results and Provides Operational Update
August 29, 2017 19:28 ET
|
ABcann Medicinals
OTTAWA, Aug. 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to release the Company's financial results for the three and six months ended...
ABcann Releases High Level CBD Product and Launches Initial Oils Strategy
August 28, 2017 05:30 ET
|
ABcann Medicinals
OTTAWA, Aug. 28, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the release of one of Canada's highest legal CBD:THC...
ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment
August 02, 2017 05:00 ET
|
ABcann Medicinals
OTTAWA, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated July 10, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (“ABcann”) and Cannabis...
ABcann Global Provides Construction and Expansion Update
July 26, 2017 07:04 ET
|
ABcann Medicinals
OTTAWA, July 26, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (the “Company”) is pleased to provide an update on the Company's construction and...
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange
July 12, 2017 08:00 ET
|
ABcann Medicinals
OTTAWA, July 12, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that its common shares have been approved for trading on the OTCQB...
ABcann and Cannabis Wheaton Announce Signing of Agreement for First Tranche $15 Million Investment
July 10, 2017 01:27 ET
|
ABcann Medicinals; Cannabis Wheaton Income Corp.
OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated May 29, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (“ABcann”) and Cannabis Wheaton Income...
ABcann Global Announces Inclusion on the Horizons Medical Marijuana Life Sciences ETF
July 05, 2017 08:55 ET
|
ABcann Medicinals
OTTAWA, July 05, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF...
ABcann Global Recruits Dr. Michael Shannon as Chief Medical Consultant
June 29, 2017 09:19 ET
|
ABcann Medicinals
OTTAWA, June 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that it has retained the services of Dr. Michael Shannon as its...